section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: orthostatic hypotension

Derm: pruritus

Endo: syndrome of inappropriate antidiuretic hormone

GI: constipation, dry mouth, dyspepsia, nausea

GU: urinary frequency

MS: leg cramps, muscle pain, postural deformities, RHABDOMYOLYSIS

Neuro: amnesia, dizziness, drowsiness, hallucinations, weakness, abnormal dreams, aggression, agitation, confusion, delirium, delusions, disorientation, dyskinesia, extrapyramidal syndrome, headache, hypertonia, impulse control disorders (gambling, sexual, uncontrolled spending, binge/compulsive eating), insomnia, paranoid ideation, psychosis, SLEEP ATTACKS, unsteadiness/falling

Misc: tooth disease

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Parkinson's Disease

Renal Impairment

Renal Impairment

Restless Leg Syndrome

Renal Impairment

US Brand Names

Mirapex ER

Action

  • Stimulates dopamine receptors in the striatum of the brain.
Therapeutic effects:
  • Decreased tremor and rigidity in Parkinson’s disease.
  • Decreased leg restlessness.

Classifications

Therapeutic Classification: antiparkinson agents

Pharmacologic Classification: dopamine agonists

Pharmacokinetics

Absorption: >90% absorbed following oral administration.

Distribution: Widely distributed.

Metabolism/Excretion: 90% excreted unchanged in urine.

Half-Life: 8 hr ( in geriatric patients and patients with renal impairment).

Canadian Brand Names

Mirapex

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown2 hr8 hr
PO-ERunknown6 hr24 hr

Patient/Family Teaching

Pronunciation

pra-mi-PEX-ole

Code

NDC Code